MYC-Mediated Ribosomal Gene Expression Sensitizes Enzalutamide-resistant Prostate Cancer Cells to EP300/CREBBP Inhibitors.
Am J Pathol. 2021 Jun;191(6):1094-1107. doi: 10.1016/j.ajpath.2021.02.017. Epub 2021 Mar 8.
Am J Pathol. 2021.
PMID: 33705753
Free article.